SAN ANTONIO, March 17, 2026--bioAffinity Technologies' new patient case study demonstrates the benefit of CyPath Lung in ...
While smoking remains the leading risk factor, other contributors include secondhand smoke, air pollution, radon exposure and ...
Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.
The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.
bioAffinity Technologies Inc BIAF shares are trading higher on Tuesday morning. The move follows the release of a new ...
Pulmonary involvement is highly prevalent in individuals with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), affecting 82.7% of patients with granulomatosis with polyangiitis ...
Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...
bioAffinity Technologies Inc. BIAF shares are down during Thursday’s premarket session. Over the last week, the stock has surged by more than 100%, as per Benzinga Pro data. The recent momentum ...
Miami Community Newspapers on MSN
Broward Health Medical Center Acquires State-of-the-Art Ion Robotic-Assisted Navigational Bronchoscopy
Minimally invasive technology enables earlier detection and faster treatment of lung cancer Broward Health Medical Center announced the acquisition of the Ion™ Endoluminal System. This ...
Amini: This requires communication from all team members, which we can typically do seamlessly now through the electronic medical record. Our medical oncologists typically take the lead but we all ...
Study confirms 96.7% overall diagnostic yield due to precise lesion targeting using digital tomosynthesis and augmented fluoroscopy with CBCT verification ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results